Level B· Emerging clinical evidence with positive signalsClinical TrialEurope PMC

Intraoperative stem cell therapy

Coelho MB., Cabral JM., Karp JM.

Clinical Trial, published in Annu Rev Biomed Eng (2012) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Annu Rev Biomed Eng (2012)
Reported sample size
—
Source database
Europe PMC
PMID
22809140
PMCID
PMC3646373
DOI
10.1146/annurev-bioeng-071811-150041
Citations
35

Abstract (original English)

Stem cells hold significant promise for regeneration of tissue defects and disease-modifying therapies. Although numerous promising stem cell approaches are advancing in clinical trials, intraoperative stem cell therapies offer more immediate hope by integrating an autologous cell source with a well-established surgical intervention in a single procedure. Herein, the major developments in intraoperative stem cell approaches, from in vivo models to clinical studies, are reviewed, and the potential regenerative mechanisms and the roles of different cell populations in the regeneration process are discussed. Although intraoperative stem cell therapies have been shown to be safe and effective for several indications, there are still critical challenges to be tackled prior to adoption into the standard surgical armamentarium.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
Stem CellsAnimalsHumansIntraoperative PeriodStem Cell TransplantationBiomedical EngineeringRegenerative MedicineRegenerationCell LineageChondrogenesis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.